智通财经APP讯，健康160(02656)发布公告，本集团预计本年度(截至2025年12月31日止年度)将取得经调整净利润(非国际财务报告准则计量)介乎人民币300万元至500万元，而截至2024年12月31日止年度(去年同期)经调整净亏损(非国际财务报告准则计量)为人民币3150万元。此为本集团经调整净利润(非国际财务报告准则计量)首次取得全年盈利。
本年度经调整净利润(非国际财务报告准则计量)转亏为盈，主要归因于以下各项综合影响：(i)收入实现同比增长，带动毛利微幅增加;及(ii)通过精细化管理及运营效率持续提升，本年度运营开支总额(包括销售及营销、研发及行政开支)大幅减少。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.